The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
about
The complex interplay of genetic and lifestyle risk factors in type 2 diabetes: an overviewObesity susceptibility loci and dietary intake in the Look AHEAD Trial.Invited commentary: Gene X lifestyle interactions and complex disease traits--inferring cause and effect from observational data, sine qua non.Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.Relationships of dietary patterns with body composition in older adults differ by gender and PPAR-γ Pro12Ala genotypeTargeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional studyPharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approachGenetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels.Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trialPerilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in hispanics of Caribbean origin.Topics in type 2 diabetes and insulin resistanceIdentifying genes for primary hypertension: methodological limitations and gene-environment interactions.PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet.Interaction between Pro12Ala polymorphism of PPARγ2 and diet on adiposity phenotypes.PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction.Plasma and amniotic fluid PPARγ is involved in the lipid metabolism of maternal-fetal interface cells.Pro12Ala variant of the PPARG2 gene increases body mass index: An updated meta-analysis encompassing 49,092 subjects.The Mediterranean diet protects against waist circumference enlargement in 12Ala carriers for the PPARgamma gene: 2 years' follow-up of 774 subjects at high cardiovascular risk.Pro12Ala polymorphism influences body composition changes in severely obese patients consuming extra virgin olive oil: a randomized clinical trialAssociations between Polymorphisms in Genes Involved in Fatty Acid Metabolism and Dietary Fat IntakesEffects of Peroxisome Proliferator-Activated Receptors, Dietary Fat Intakes and Gene–Diet Interactions on Peak Particle Diameters of Low-Density LipoproteinsErythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men
P2860
Q26997813-CAF4FE49-951D-4E09-95D5-652FCB3E9D11Q30514020-BAF6E18B-794B-4006-955A-C14DEC97F874Q33694207-6B6BAB91-CADC-497B-9689-D233D70406B8Q33793843-7E909364-1261-48F4-B686-65C81798D4D2Q34152736-ED7CF182-B660-4A6C-BEDC-87B3E467C32CQ34294192-62945ED6-6C0D-4D2B-A316-E7935B8691E4Q34641723-165E7819-EB09-41E9-8D45-4DC39A74D7FAQ34803775-1B3198D5-6688-437E-B66F-8F891D22BE13Q35039274-91917E5B-5FB9-46BC-9076-6844571F8511Q35096813-749A167A-483F-4E75-8551-6060D7526FBAQ35104849-CA9EF880-6523-49E2-AD8F-9BBDF66EF616Q35688206-815B5962-5193-44EB-B58F-242773437795Q35902855-B40AD146-5AA6-488D-9EF3-55FB4CAB2ABEQ36120556-8D54153D-9338-443A-AC6F-92892830D86FQ37000570-69E7FA81-C0F7-4465-B978-E2856A163F4EQ37067180-398011EE-2D50-4E7C-A441-0F4056BC7EA8Q37324246-EA04DB6D-914C-4D35-BEB7-396B9DC61BF6Q37634074-4AA604F3-4834-4840-9853-5BD423CCE913Q38262459-2485DFA5-1D92-4C7E-8F6E-C18BC44836FCQ45960080-293040D8-B4FB-4406-9AC0-6A4FB2562B5FQ50202388-6BD8D9EB-1E44-4570-B777-032E25FFA694Q50999994-416DE0BD-5C59-4A35-82B1-5EAEC7D81CEBQ51779625-322435B4-CF59-4FA1-8FC9-3BB0CF138560Q56526329-10A74A93-1293-4086-B0C2-ABFD95DEB78CQ57316294-95C585EB-E59B-49AE-A2E0-CABC73E72B59Q57316298-DADC11FF-6BDE-496D-AB2B-31B10762DF1DQ57659526-14258408-2A38-428F-99C1-CEBD1D21D9ED
P2860
The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
The Pro12Ala variant at the pe ...... e Diabetes Prevention Program.
@ast
The Pro12Ala variant at the pe ...... e Diabetes Prevention Program.
@en
type
label
The Pro12Ala variant at the pe ...... e Diabetes Prevention Program.
@ast
The Pro12Ala variant at the pe ...... e Diabetes Prevention Program.
@en
prefLabel
The Pro12Ala variant at the pe ...... e Diabetes Prevention Program.
@ast
The Pro12Ala variant at the pe ...... e Diabetes Prevention Program.
@en
P2093
P2860
P50
P1433
P1476
The Pro12Ala variant at the pe ...... he Diabetes Prevention Program
@en
P2093
D Altshuler
Diabetes Prevention Program Research Group
J C Florez
K A Jablonski
L Delahanty
W C Knowler
P2860
P2888
P304
P356
10.1007/S00125-007-0826-6
P577
2007-09-27T00:00:00Z
P5875
P6179
1030776838